Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 3 1Phase 2 1Phase 1 1

Status

Completed 4

Sponsor Class

NIH 4

Study Type

Interventional 4

Sponsor

Cancer Type

Sarcoma 7Lymphoid 4

Conditions

Hodgkin Disease 50Lymphoma 45Lymphoma, Large B-Cell, Diffuse 10Lymphoma, Non-Hodgkin 9Lymphoma, Large-Cell, Immunoblastic 6Lymphoma, Follicular 6HIV Infections 5Acquired Immunodeficiency Syndrome 4Recurrence 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Dendritic Cell Sarcoma, Interdigitating 2Cardiotoxicity 2Burkitt Lymphoma 2Waldenstrom Macroglobulinemia 1Nervous System Neoplasms 1Neoplasms, Plasma Cell 1Neoplasms 1Multiple Myeloma 1Lymphoma, T-Cell, Peripheral 1Lymphoma, Mantle-Cell 1Lymphoma, B-Cell, Marginal Zone 1Lugano Classification Limited Stage Hodgkin Lymphoma AJCC v8 1Leukemia, Lymphocytic, Chronic, B-Cell 1Hematologic Diseases 1Disease 1AIDS-Related Complex 1

Interventions

Doxorubicin 6Cyclophosphamide 6Vincristine 5Dexamethasone 5Zidovudine 4Methotrexate 4Leucovorin 4Cytarabine 4Bleomycin 4Filgrastim 3sargramostim 2Etoposide 2Allopurinol 2tocilizumab 1fludarabine phosphate 1fludarabine 1Vinblastine 1Valganciclovir 1Thiotepa 1Tacrolimus 1Rituximab 1Prednisone 1Mitoxantrone 1Mitoguazone 1Methylprednisolone Hemisuccinate 1Methylprednisolone 1Melphalan 1Interviews as Topic 1HIV Testing 1Genes 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Acquired Immunodeficiency Syndrome × Bleomycin × Lymphoid × Clear all
NCT00000658 2021-11-03

A Phase III Randomized Trial of Low-Dose Versus Standard-Dose mBACOD Chemotherapy With rGM-CSF for Treatment of AIDS-Associated Non-Hodgkin's Lymphoma

National Institute of Allergy and Infectious Diseases (NIAID)

Phase 3 Completed
250 enrolled
Lymphoid

Acquired Immunodeficiency Syndrome, Lymphoma, Non-Hodgkin, HIV Infections

NCT00000703 2021-11-03

Chemotherapy and Azidothymidine, With or Without Radiotherapy, for High Grade Lymphoma in AIDS-Risk Group Members

National Institute of Allergy and Infectious Diseases (NIAID)

Phase NA Completed
45 enrolled
Lymphoid

Acquired Immunodeficiency Syndrome, Lymphoma, Lymphoma, Non-Hodgkin, HIV Infections

NCT00000689 2021-11-02

Phase I Trial of mBACOD and Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) in AIDS-Associated Large Cell, Immunoblastic, and Small Non-cleaved Lymphoma

National Institute of Allergy and Infectious Diseases (NIAID)

Phase 1 Completed
18 enrolled
Lymphoid

Acquired Immunodeficiency Syndrome, Lymphoma, Non-Hodgkin, Nervous System Neoplasms, HIV Infections

NCT00000626 2021-10-27

Phase II Study of Filgrastim (G-CSF) Plus ABVD in the Treatment of HIV-Associated Hodgkin's Disease

National Institute of Allergy and Infectious Diseases (NIAID)

Phase 2 Completed
27 enrolled
Lymphoid

Acquired Immunodeficiency Syndrome, AIDS-Related Complex, Hodgkin Disease, HIV Infections

Data powered by HemOnc (CC BY 4.0) Colophon âš¡